CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Kaneka Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Kaneka Corp
Nakanoshima Festival Tower
2-3-18, Nakanoshima, Kita-ku
Phone: +81 662265050p:+81 662265050 OSAKA-SHI, OSK  530-8288  Japan Ticker: 41184118
Business Summary
KANEKA CORPORATION is a Japan-based company engaged in four business segments. The Material Solutions Unit segment includes general purpose vinyl chloride resin, caustic soda, polyvinyl chloride special resin, modifier, modified silicone polymer, biodegradable polymer. Quality of Life Solutions Unit segment includes expanded styrene resin and molded products, extruded polystyrene foam boards, bead method expanded polyolefin, solar circuit method, super heat resistant polyimide films, optical materials, super heat conductive graphite sheets, solar cells, storage batteries for housing and others. The Health Care Solutions Unit segment includes medical devices, low molecular weight pharmaceutical raw materials, biopharmaceuticals, etc. The Nutrition Solutions Unit segment includes functional food ingredients, margarine, shortening, baker's yeast, spices, antifreeze ingredients, functional fertilizers and feeds.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20243/31/2024Yes----

Industries
SIC Code Description
2899 Chemicals and chemical preparations, not elsewhere classified
2869 Industrial organic chemicals, not elsewhere classified
2819 Industrial inorganic chemicals, not elsewhere classified
2821 Plastics materials, synthetic resins, and nonvulcanizable elastomers
2833 Medicinal chemicals and botanical products
3674 Semiconductors and related devices
2079 Shortening, table oils, margarine, and other edible fats and oils
2824 Manmade organic fibers, except cellulosic
2874 Phosphatic fertilizers
6411 Insurance agents, brokers, and service

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Representative Director KimikazuSugawara 77 4/1/2014 6/1/2000
President, Representative Director KazuhikoFujii 63 4/1/2024 6/1/2012
Finance Director, Managing Executive Officer, Director ToshioKomori 61 6/1/2023 6/1/2015
11 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Japan Medical Device Technology Co., Ltd. Tabaru 2020-3 Mashiki-machi Japan
Kaneka Singapore Co. (Pte) Ltd. 29 Gul Crescent Singapore Singapore
Kaneka Belgium N.V. Nijverheidsstraat 16 Westerlo-Oevel Belgium
3 additional Subsidiary records available in full report.

Business Names
Business Name
4118
Cemedine Automotive North America Co., Ltd
Cemedine Co., Ltd.
68 additional Business Names available in full report.

General Information
Number of Employees: 11,544 (As of 3/31/2024)
Outstanding Shares: 62,933,610 (As of 9/30/2024)
Shareholders: 20,591
Stock Exchange: TYO
Federal Tax Id: 760050292
Fax Number: +81 662265037


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024